SLC39A9 and ovarian carcinoma: However, little was known regarding the specific physiological role of ZIP9 until 2014, when Thomas and co-workers discovered that ZIP9 is highly expressed in breast and ovarian cancer cell lines and that is bound by androgen hormones [5].